627 related articles for article (PubMed ID: 11680567)
41. In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice.
Blazar BR; Taylor PA; Linsley PS; Vallera DA
Blood; 1994 Jun; 83(12):3815-25. PubMed ID: 7515723
[TBL] [Abstract][Full Text] [Related]
42. Cutting edge: the relative distribution of T cells responding to chemically dominant or minor epitopes of lysozyme is not affected by CD40-CD40 ligand and B7-CD28-CTLA-4 costimulatory pathways.
DiPaolo RJ; Unanue ER
J Immunol; 2002 Sep; 169(6):2832-6. PubMed ID: 12218093
[TBL] [Abstract][Full Text] [Related]
43. The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo.
Yuan X; Salama AD; Dong V; Schmitt I; Najafian N; Chandraker A; Akiba H; Yagita H; Sayegh MH
J Immunol; 2003 Mar; 170(6):2949-55. PubMed ID: 12626546
[TBL] [Abstract][Full Text] [Related]
44. Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells.
Bumgardner GL; Orosz CG
Immunol Rev; 2000 Apr; 174():260-79. PubMed ID: 10807522
[TBL] [Abstract][Full Text] [Related]
45. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Sharpe AH; Vallera DA
J Immunol; 1999 Jun; 162(11):6368-77. PubMed ID: 10352249
[TBL] [Abstract][Full Text] [Related]
46. Anti-CD28 antibodies modify regulatory mechanisms and reinforce tolerance in CD40Ig-treated heart allograft recipients.
Guillonneau C; Séveno C; Dugast AS; Li XL; Renaudin K; Haspot F; Usal C; Veziers J; Anegon I; Vanhove B
J Immunol; 2007 Dec; 179(12):8164-71. PubMed ID: 18056359
[TBL] [Abstract][Full Text] [Related]
47. Flt3-L augments the engraftment of donor-derived bone marrow cells when combined with sublethal irradiation and costimulatory (CD28/B7 and CD40/CD40L) blockade.
Woodward JE; Salam A; Logar AJ; Schaefer AT; Rao AS
Cell Transplant; 2002; 11(2):147-59. PubMed ID: 12099638
[TBL] [Abstract][Full Text] [Related]
48. New insights in CD28-independent allograft rejection.
Habicht A; Najafian N; Yagita H; Sayegh MH; Clarkson MR
Am J Transplant; 2007 Aug; 7(8):1917-26. PubMed ID: 17617854
[TBL] [Abstract][Full Text] [Related]
49. Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28.
Saito K; Sakurai J; Ohata J; Kohsaka T; Hashimoto H; Okumura K; Abe R; Azuma M
J Immunol; 1998 May; 160(9):4225-31. PubMed ID: 9574523
[TBL] [Abstract][Full Text] [Related]
50. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses.
Lee RS; Yamada K; Womer KL; Pillsbury EP; Allison KS; Marolewski AE; Geng D; Thall AD; Arn JS; Sachs DH; Sayegh MH; Madsen JC
J Immunol; 2000 Mar; 164(6):3434-44. PubMed ID: 10706740
[TBL] [Abstract][Full Text] [Related]
51. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
[TBL] [Abstract][Full Text] [Related]
52. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo.
Yamada A; Salama AD; Sho M; Najafian N; Ito T; Forman JP; Kewalramani R; Sandner S; Harada H; Clarkson MR; Mandelbrot DA; Sharpe AH; Oshima H; Yagita H; Chalasani G; Lakkis FG; Auchincloss H; Sayegh MH
J Immunol; 2005 Feb; 174(3):1357-64. PubMed ID: 15661893
[TBL] [Abstract][Full Text] [Related]
53. Different mechanisms of cardiac allograft rejection in wildtype and CD28-deficient mice.
Szot GL; Zhou P; Rulifson I; Wang J; Guo Z; Kim O; Newel KA; Thistlethwaite JR; Bluestone JA; Alegre ML
Am J Transplant; 2001 May; 1(1):38-46. PubMed ID: 12095035
[TBL] [Abstract][Full Text] [Related]
54. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
[TBL] [Abstract][Full Text] [Related]
55. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism.
Pearson TC; Alexander DZ; Hendrix R; Elwood ET; Linsley PS; Winn KJ; Larsen CP
Transplantation; 1996 Apr; 61(7):997-1004. PubMed ID: 8623206
[TBL] [Abstract][Full Text] [Related]
56. Expression of inducible lymphocyte costimulatory molecules in human renal allograft.
Biancone L; Segoloni G; Turello E; Donati D; Bussolati B; Piccoli G; Camussi G
Nephrol Dial Transplant; 1998 Mar; 13(3):716-22. PubMed ID: 9550652
[TBL] [Abstract][Full Text] [Related]
57. Prolonged allograft survival following ex vivo blockade of costimulatory signals B7-1/2 and CD40.
Steurer W; Oellinger R; Perwanger F; Brandacher G; Obrist P; Klima G; Margreiter R
Transplant Proc; 2001; 33(1-2):274-5. PubMed ID: 11266816
[No Abstract] [Full Text] [Related]
58. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
Cong L; Wang SF; Zhao ZL; Yang RY
Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
[TBL] [Abstract][Full Text] [Related]
59. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection.
Hancock WW; Sayegh MH; Zheng XG; Peach R; Linsley PS; Turka LA
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13967-72. PubMed ID: 8943044
[TBL] [Abstract][Full Text] [Related]
60. Costimulatory blockade-mediated lung allograft acceptance is abrogated by overexpression of Bcl-2 in the recipient.
Okazaki M; Sugimoto S; Lai J; Kornfeld CG; Hotchkiss RS; Richardson SB; Li W; Kreisel FH; Huang HJ; Patterson GA; Krupnick AS; Gelman AE; Kreisel D
Transplant Proc; 2009; 41(1):385-7. PubMed ID: 19249562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
